-
disease (MASLD),
previously known as non-alcoholic
fatty liver disease (
NAFLD), is a type of
chronic liver disease. This
condition is
diagnosed when there...
-
steatotic liver disease (MASLD,
formerly "non-alcoholic
fatty liver disease" (
NAFLD)) and alcohol-****ociated
liver disease (ALD), with the
category "metabolic...
-
steatotic liver disease,
previously called non-alcoholic
fatty liver disease or
NAFLD),
heroin abuse,
chronic hepatitis B, and
chronic hepatitis C.
Heavy drinking...
- the GoI in 2021 into
Integration of Non-Alcoholic
Fatty Liver Disease (
NAFLD)
within the
ambit of NCDs,
making India the
first country globally (covered...
-
insulin resistance, hypertriglyceridemia, non-alcoholic
fatty liver disease (
NAFLD) and
metabolic syndrome.
Lipodystrophy can be
divided into the following...
- X receptor, a
therapeutic target for
nonalcoholic fatty liver disease (
NAFLD).
During the COVID-19 pandemic,
ivermectin was
researched for
possible utility...
-
developing nonalcoholic fatty liver disease (
NAFLD). BRI and AVI also
accurately stratified diagnosis of
NAFLD by race, age, and gender. The BRI has proved...
-
April 2023). "The
global epidemiology of
nonalcoholic fatty liver disease (
NAFLD) and
nonalcoholic steatohepatitis (NASH): a
systematic review". Hepatology...
-
Liver Disease (MASLD) (previously non-alcoholic
fatty liver disease or
NAFLD) Alcohol-****ociated (Alcohol-related)
Liver Disease (ALD) Risk
factors for...
- drug for the
treatment of type 2
diabetes mellitus, dyslipidemia, NASH and
NAFLD It is
approved for use in
India by the Drug
Controller General of India...
